MabVax Therapeutics Holdings, Inc., a clinical-stage biotechnology company with a fully human antibody discovery platform focused on the development of antibody-based products to address unmet medical needs in the treatment of cancer, today filed a Verified Petition for Relief Under 8 Del.
July 27, 2018
· 3 min read